William T. Andrews - Aug 2, 2021 Form 4 Insider Report for Flexion Therapeutics Inc (FLXN)

Role: Chief Medical Officer
Signature: /s/ Mark S. Levine, Attorney-in-Fact
Stock symbol: FLXN
Transactions as of: Aug 2, 2021
Transactions value $: $0
Form type: 4
Date filed: 8/4/2021, 04:09 PM
Previous filing: Jul 6, 2021
Next filing: Nov 19, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	FLXN	Common Stock	Award	$0	+34.3K		$0.00	34.3K	Aug 2, 2021	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	FLXN	Stock option (right to buy)	Award	$0	+206K		$0.00	206K	Aug 2, 2021	Common Stock	206K	$6.25	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents a restricted stock unit award granted under the Issuer's 2013 Equity Incentive Plan.
F2	25% of the shares subject to the option shall vest on the one-year anniversary of July 1, 2021 (the "Vesting Commencement Date"), and 1/48th of the shares subject to the option shall vest each month following the one-year anniversary of the Vesting Commencement Date, so that all of the shares subject to the options shall be vested four years after the Vesting Commencement Date.